Superworth

China Pharma EPS CPHI

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.43
Latest quarter, Q2 FY26
−$0.04
Fiscal year 2025
−$0.75

China Pharma's earnings per share was −$0.43 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.04.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.75n/a
FY2024−$2.79n/a
FY2023n/an/a
FY2021−$40.50n/a
FY2020−$35.00n/a
FY2019−$240.00n/a
FY2018−$120.00n/a
FY2017−$220.00n/a
FY2016−$110.00n/a
FY2015−$65.00−230%
FY2012$50.00−77%
FY2011$220.00n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.04n/a−$0.43
Q1 FY26−$0.04n/a−$0.55
Q4 FY25−$0.18n/a−$0.75
Q3 FY25−$0.17n/a−$1.10
Q2 FY25−$0.16n/a−$1.58
Q1 FY25−$0.24n/a−$2.31
Q4 FY24−$0.53n/a−$2.79
Q3 FY24−$0.65n/a−$3.96
Q2 FY24−$0.89n/a−$6.21
Q1 FY24−$0.72n/an/a
Q4 FY23−$1.70n/an/a
Q3 FY23−$2.90n/an/a

Against its peers

Companies in Drug Manufacturers - General nearest China Pharma's size, closest first, today.

CompanyEPS, 12 monthsGrowth
CPHIChina Pharma−$0.43
ATNMActinium Pharmaceuticals$0.36
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
NATRNatures Sunshine Products$1.01+36% a year
Peer median$0.38

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on China Pharma

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.